Cannabis operator GTBIF stock down 17% YTD: Should you buy the dip?
Shares of Green Thumb Industries GTBIF, one of the largest cannabis operators by market capitalization, have been declining over the past few years. This pullback reflects regulatory hurdles and …
SNDL Remains Cheap But Risky
SNDL trades at a discount to tangible book value and maintains a debt-free, cash-rich balance sheet, supporting downside protection. Read why SNDL stock is a hold.
Village Farms Shows Strong Q4 Performance, But Cannabis Sector Remains Weak (Rating Downgrade)
Village Farms reported strong Q4-2025 financial performance with increasing revenue and net income. Read why I changed my rating from a Buy to a Hold for VFF stock.
The one IRS rule keeping cannabis stocks down despite record cash flow
Quick Read Trulieve (TCNNF) generated $228.6M in free cash flow during 2025 on $1.18B in revenue but carries $668M in uncertain 280E tax liabilities that would be eliminated by rescheduling. Green …
Canopy Growth: Is there any hope left for this beaten-down stock?
Shares of Canopy Growth have crashed more than 99% in the past five years.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Thinking about buying Canopy Growth stock? You may want to wait for this to happen first
The main reason for investing in Canopy Growth over the years has been due to the hope that the U.S. might legalize marijuana.
Cannabis operator CRON rises 46% in a year: Time to buy, sell or hold?
Shares of Cronos Group CRON have staged a strong recovery over the past year. The Canada-based cannabis operator’s shares have risen 46% in the said time frame, significantly outperforming the …
This cannabis stock will beat the market, analyst says
Haywood Capital Markets analyst Neal Gilmer has reiterated his “Buy” rating and $1.30 target price on Rubicon Organics …
Debt dominates cannabis capital raises as equity deals dry up
The cannabis industry has transitioned to a more commoditized market characterized by price declines and minimal organic growth.
11 Best Pot Stocks to Buy According to Hedge Funds
The global cannabis industry is undergoing a structural transformation as legalization expands for both medical and adult use across multiple regions.
Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom?
Investors interested in the marijuana industry will be familiar with Aurora Cannabis (NASDAQ: ACB). This pot grower has been one of the bigger names in the market at least since the end of the last …
Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom?
Investors interested in the marijuana industry will be familiar with Aurora Cannabis (NASDAQ: ACB). This pot grower has been one of the bigger names in the market at least since the end of the last …
Cronos: Geographic Expansion Backed By A Strong Balance Sheet
Cronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with $784M in cash. Learn more about CRON stock here.
Don’t even think about buying Canopy Growth stock until you read this brutal reality check
Canopy Growth is a penny stock for a reason, so only the most aggressive investors should even be looking at it.
Recent Comments